The US Food and Drug Administration is backing the extension of a copyright enforcement policy that allows access to medical device software, including for cybersecurity purposes.
Suzanne Schwartz, director of Office of Strategic Partnerships and Technology Innovation (OST) at FDA, issued a letter in June expressing...





